NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cells

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4946-4952

  Zarour, H M ^a   Storkus, W J ^a   Brusic, V ^a   Williams, E ^a   Kirkwood, J M ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; CROSS REACTION; EPITOPE MAPPING; GENE EXPRESSION REGULATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOMA; MOLECULAR CLONING; MOLECULAR RECOGNITION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEINS; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0034282998     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Human CD4+ T cells specially recognize a shared melanoma-associated antigen encoded by the tyrosinase gene
2. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
3. Melanoma cells present a MAGE-3 epitope to CD4+ cytotoxic T cells in association with histocompatibility leukocyte antigen DRII
4. Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3
5. Biochemical identification of a mutated human melanoma antigen recognized by CD4 + T cells
6. Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
7. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4+ T cells
8. Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
9. The role CD4+ T cell responses in antitumor immunity
10. CD4+ T cells and their role in antitumor immune responses
11. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
12. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility antigen (HLA)-A2-binding epitopes
13. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
14. Melan-A/MART-1 51-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells
15. Neural network-based prediction of candidate T-cell epitopes
16. Prediction of MHC class-II binding peptides using an evolutionary algorithm and artificial neural network
17. Detection of biotinylated cell surface receptors and MHC molecules in a capture ELISA: A rapid assay to measure endocytosis
18. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal-calf serum-free conditions
19. The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor as a spot in response to peptide antigens
20. Class II MHC molecules can use the endogenous pathway of antigen presentation
21. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help
22. Dendritic cells acquire antigen from apoptotic cells and induce class-I restricted CTLs
23. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class-II negative tumors
24. Extracellular antigen processing and presentation by immature dendritic cells
25. LAGE-1, a new gene with tumor specificity
26. Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides
27. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association
28. Binding specificity of a class II-restricted hepatitis B epitope by DR molecules from responder and non-responder vaccine recipients
29. HLA-DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions
30. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4, 0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-I-expressing melanoma